Conduct of studies to evaluate the toxicity of trimethylsilyldiazomethane in laboratory animals for the National Toxicology Program (NTP)

为国家毒理学计划 (NTP) 开展研究,评估三甲基硅基重氮甲烷对实验动物的毒性

基本信息

  • 批准号:
    10024900
  • 负责人:
  • 金额:
    $ 13.99万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-04-15 至 2020-04-14
  • 项目状态:
    已结题

项目摘要

The goal of this project is to provide support of National Toxicology Program (NTP) hazard identification activities targeted toward the prevention of diseases or adverse effects caused by environmental exposure to chemical or physical agents. Toxicity testing is an important aspect of public health research in that it serves to identify chemicals that are hazardous to human health. Proper conduct of toxicology studies is required to ensure that the resulting data are reliable. This project involves the characterization of the acute toxicity of trimethylsilyldiazomethane (TMSD). TMSD is a methylating agent used in synthetic chemistry. It is marketed as a safe replacement for diazomethane, primarily due to a lower explosive potential. However, two chemists died of acute pulmonary edema while working with TMSD in the laboratory. NTP is performing toxicity studies in order to further examine the potential for TMSD to induce pulmonary toxicity. The data from this project will be used in the development of sound, scientific conclusions about the potential toxicity and carcinogenicity of TMSD in rats and mice and ultimately supports the risk assessment efforts of National Toxicology Program and other federal agencies. In addition, the public can be adequately informed about risk factors arising from exposure to TMSD. Keywords: toxicity, inhalation, trimethylsilyldiazomethane, lung
该项目的目标是为国家毒理学计划(NTP)的危害识别活动提供支持,这些活动旨在预防因环境暴露于化学或物理制剂而引起的疾病或不良影响。毒性测试是公共卫生研究的一个重要方面,因为它有助于确定对人类健康有害的化学品。需要适当进行毒理学研究,以确保所得数据可靠。本项目涉及三甲基硅基重氮甲烷(TMSD)的急性毒性表征。TMSD是一种用于合成化学的甲基化剂。它作为重氮甲烷的安全替代品销售,主要是由于爆炸潜力较低。然而,两名化学家在实验室使用TMSD时死于急性肺水肿。NTP正在进行毒性研究,以进一步检查TMSD诱导肺毒性的可能性。 该项目的数据将用于制定关于TMSD在大鼠和小鼠中的潜在毒性和致癌性的合理科学结论,并最终支持国家毒理学计划和其他联邦机构的风险评估工作。此外,市民亦可充分了解接触TMSD所引致的风险因素。 关键词:毒性,吸入,三甲基硅基重氮甲烷,肺

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

BARNEY SPARROW其他文献

BARNEY SPARROW的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('BARNEY SPARROW', 18)}}的其他基金

Production of TempOSeq data for the DrugMatrix reference library
为 DrugMatrix 参考库生成 TempOSeq 数据
  • 批准号:
    10710454
  • 财政年份:
    2017
  • 资助金额:
    $ 13.99万
  • 项目类别:
Systematic Evaluation of the Application of Zebrafish in Toxicology (SEAZIT) Phase 2
斑马鱼毒理学应用的系统评价 (SEAZIT) 第 2 阶段
  • 批准号:
    10213572
  • 财政年份:
    2017
  • 资助金额:
    $ 13.99万
  • 项目类别:
Support for the CONDUCT OF STUDIES TO EVALUATE THE IMPACT OF GENETIC BACKGROUND AND POTENTIAL TREATMENTS ON SEVERE SARS-CoV-2 INDUCED PNEUMONIA FOR THE NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIEN
支持国家环境卫生科学研究所开展研究,评估遗传背景和潜在治疗方法对严重 SARS-CoV-2 引起的肺炎的影响
  • 批准号:
    10281194
  • 财政年份:
    2017
  • 资助金额:
    $ 13.99万
  • 项目类别:
Evaluation of HepaRG cells as a screen for chemical toxicity and assay optimization
评估 HepaRG 细胞作为化学毒性筛选和测定优化的作用
  • 批准号:
    10700772
  • 财政年份:
    2017
  • 资助金额:
    $ 13.99万
  • 项目类别:
Evaluation of multiple test agents for functional cardiovascular changes in rats
多种测试药物对大鼠功能性心血管变化的评价
  • 批准号:
    10932828
  • 财政年份:
    2017
  • 资助金额:
    $ 13.99万
  • 项目类别:
SUPPORT FOR THE CONDUCT OF STUDIES TO EVALUATE TOXICOGENOMIC RESPONSE OF DO MOUSE CELL LINES EXPOSED TO CHEMICALS FOR THE NTP
支持开展研究以评估暴露于 NTP 化学品的 DO 小鼠细胞系的毒理学反应
  • 批准号:
    10026342
  • 财政年份:
    2017
  • 资助金额:
    $ 13.99万
  • 项目类别:
SUPPORT FOR THE CONDUCT OF STUDIES TO EVALUATE THE TOXICOLOGIC POTENTIAL OF Garcinia cambogia FOR THE NTP
支持开展研究以评估藤黄果对 NTP 的毒理学潜力
  • 批准号:
    10213574
  • 财政年份:
    2017
  • 资助金额:
    $ 13.99万
  • 项目类别:
NTP Study Conducted at NIOSH- Evaluation of the Subchronic Toxicity of a Satratoxin Producing Chemotype Strain of Stachybotrys Chartarum
NIOSH 进行的 NTP 研究 - 产 Satratoxin 的 Stachybotrys Chartarum 化学型菌株的亚慢性毒性评估
  • 批准号:
    9795258
  • 财政年份:
    2017
  • 资助金额:
    $ 13.99万
  • 项目类别:
Support for the Conduct of Studies to Evaluate the Impact of Genetic Background and Potential Treatments of SARS-CoV-2 Induced Pneumonia
支持开展研究以评估遗传背景的影响和 SARS-CoV-2 引起的肺炎的潜在治疗方法
  • 批准号:
    10700771
  • 财政年份:
    2017
  • 资助金额:
    $ 13.99万
  • 项目类别:
Evaluation of multiple test agents for functional cardiovascular changes in rats
多种测试药物对大鼠功能性心血管变化的评价
  • 批准号:
    10710453
  • 财政年份:
    2017
  • 资助金额:
    $ 13.99万
  • 项目类别:

相似海外基金

Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
  • 批准号:
    10591918
  • 财政年份:
    2023
  • 资助金额:
    $ 13.99万
  • 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
  • 批准号:
    23K15383
  • 财政年份:
    2023
  • 资助金额:
    $ 13.99万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
  • 批准号:
    23H03556
  • 财政年份:
    2023
  • 资助金额:
    $ 13.99万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
  • 批准号:
    23K17212
  • 财政年份:
    2023
  • 资助金额:
    $ 13.99万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
  • 批准号:
    22H03519
  • 财政年份:
    2022
  • 资助金额:
    $ 13.99万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
  • 批准号:
    563657-2021
  • 财政年份:
    2022
  • 资助金额:
    $ 13.99万
  • 项目类别:
    Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10521849
  • 财政年份:
    2022
  • 资助金额:
    $ 13.99万
  • 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10671022
  • 财政年份:
    2022
  • 资助金额:
    $ 13.99万
  • 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
  • 批准号:
    10670918
  • 财政年份:
    2022
  • 资助金额:
    $ 13.99万
  • 项目类别:
Adverse Effects of Using Laser Diagnostics in High-Speed Compressible Flows
在高速可压缩流中使用激光诊断的不利影响
  • 批准号:
    RGPIN-2018-04753
  • 财政年份:
    2022
  • 资助金额:
    $ 13.99万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了